Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: Interpretation of NMR Spectra in AMD – V 2.0

Posted on By

Analytical Method Development: Interpretation of NMR Spectra in AMD – V 2.0

Standard Operating Procedure for Interpretation of NMR Spectra in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/112/2025
Supersedes SOP/AMD/112/2022
Page No. Page 1 of 14
Issue Date 19/05/2025
Effective Date 20/05/2025
Review Date 19/05/2026

1. Purpose

This SOP describes the standardized procedure for the interpretation of NMR spectra obtained during analytical method development. It ensures uniform practices for structure elucidation, identity confirmation, and purity assessment of active pharmaceutical ingredients

(APIs) and impurities.

2. Scope

This SOP is applicable to all 1D and 2D NMR spectral interpretation activities performed in the Analytical Method Development (AMD) department, covering 1H, 13C, COSY, HSQC, and HMBC spectra.

3. Responsibilities

  • NMR Analyst: Analyzes raw data, processes spectra, and performs chemical shift and coupling analysis.
  • Method Developer: Correlates NMR findings with known structures and proposes identification or confirmation.
  • QA Officer: Ensures compliance of documentation and interpretation with SOPs and regulatory expectations.
  • Head – AMD: Reviews and approves final interpretation reports.

4. Accountability

The Head of Analytical Method Development is accountable for the quality and compliance of spectral interpretation reports used for structural confirmation and impurity identification.

See also  Analytical Method Development: Preparation of AMD Master Plan - V 2.0

5. Procedure

5.1 Raw Data Review and Baseline Assessment

  1. Open the acquired NMR data file using the validated NMR processing software.
  2. Assess:
    • Baseline correction
    • Phase correction (manual or auto)
    • Signal-to-noise ratio
    • Solvent peak position and suppression effectiveness
  3. Mark all peaks for further interpretation and note any unusual baseline noise.
  4. Log this information in Annexure-1: Baseline Review Checklist.

5.2 Chemical Shift Assignment

  1. Calibrate chemical shifts using standard solvent signals:
    • CDCl3: 7.26 ppm (1H), 77.0 ppm (13C)
    • DMSO-d6: 2.50 ppm (1H), 39.5 ppm (13C)
  2. Use integration, multiplicity, and coupling constants to assign each signal.
  3. Document chemical shift table in Annexure-2: Shift Assignment Table.

5.3 Multiplicity and Coupling Analysis

  1. Classify signals as singlet (s), doublet (d), triplet (t), quartet (q), multiplet (m), or broad (br).
  2. Determine J-values (Hz) between coupled protons using line separation.
  3. Correlate splitting patterns with structural groups (e.g., aromatic systems, methyl groups, CH2, CH3).
  4. Cross-reference expected vs observed patterns.
  5. Record in Annexure-3: Coupling and Multiplicity Log.

5.4 Integration and Proton Count Verification

  1. Confirm total proton count by comparing relative integrations to known structure.
  2. Ensure the total integration matches theoretical proton number within ±10% tolerance.
  3. Highlight discrepancies and investigate possible overlapping or exchangeable protons.
  4. Document in Annexure-4: Proton Count Verification Sheet.
See also  Analytical Method Development: UV Spectrophotometric Method Development - V 2.0

5.5 Structural Correlation

  1. Map each assigned signal to respective atoms in the proposed chemical structure.
  2. Use correlation diagrams to represent assignments visually.
  3. In case of multiple tautomers or stereoisomers, identify possible assignments using 2D spectra (if available).
  4. Attach chemical structure with annotated shifts to final report.
  5. Log in Annexure-5: Structural Correlation Map.

5.6 Optional 2D Spectral Interpretation

  1. If available, analyze COSY, HSQC, or HMBC spectra to confirm:
    • Through-bond (scalar) couplings
    • Carbon–proton connectivity
    • Long-range heteronuclear interactions
  2. Overlay 2D maps with 1D data for signal confirmation.
  3. Document observations in Annexure-6: 2D Spectra Interpretation Log.

5.7 Final Review and Reporting

  1. Compile all annexures and attach processed spectra, tables, and annotated structures.
  2. Ensure:
    • Signal-to-noise ≥ 10:1 for key peaks
    • No missing or extra peaks unaccounted for
    • Consistency across replicates
  3. Review report internally, then submit for QA approval and Head–AMD sign-off.

6. Abbreviations

  • NMR: Nuclear Magnetic Resonance
  • ppm: Parts Per Million
  • J: Coupling Constant
  • HSQC: Heteronuclear Single Quantum Coherence
  • HMBC: Heteronuclear Multiple Bond Correlation
  • SOP: Standard Operating Procedure

7. Documents

  1. Baseline Review Checklist – Annexure-1
  2. Shift Assignment Table – Annexure-2
  3. Coupling and Multiplicity Log – Annexure-3
  4. Proton Count Verification Sheet – Annexure-4
  5. Structural Correlation Map – Annexure-5
  6. 2D Spectra Interpretation Log – Annexure-6
See also  Analytical Method Development: SOP for Verification of Analytical Procedures - V 2.0

8. References

  • ICH Q6A – Specifications
  • USP <761> – Nuclear Magnetic Resonance
  • Textbook: Organic Structure Determination Using NMR Spectroscopy

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Baseline Review Checklist

Sample ID Solvent Baseline Corrected Phase Adjusted Comments
NMR-112-A CDCl3 Yes Yes Minor noise near solvent peak

Annexure-2: Shift Assignment Table

δ (ppm) Assignment Multiplicity J (Hz) Integration
7.26 Aromatic-H m 8.2 1H
2.35 CH3 s – 3H

Annexure-3: Coupling and Multiplicity Log

CH3 singlet confirms isolation; aromatic multiplet split over 4 protons indicating substitution pattern consistent with proposed structure.

Annexure-4: Proton Count Verification Sheet

The total observed integral matches theoretical 8 protons for target molecule within 5% deviation.

Annexure-5: Structural Correlation Map

Annotated structure attached with atom labels and assigned δ values confirming identity.

Annexure-6: 2D Spectra Interpretation Log

HSQC confirmed one-to-one C–H connectivity. HMBC cross-peaks supported quinoline core and methylene linkage.

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Added 2D NMR correlation and annexure templates Annual SOP Update
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Gel Manufacturing: SOP for Visual Inspection of Gel Batches – V 2.0
Next Post: Creams: SOP for Checking Tube-Filling Volumes during Production – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version